These results reflect Houston Colon’s published peer-reviewed data, not projections or averages drawn from outside studies. See how these outcomes compare to conventional approaches.
No abdominal wall incision — and why that matters
In conventional colorectal surgery, whether open or laparoscopic, a surgeon must make an abdominal incision to extract the diseased colon segment. That incision is where the majority of serious post-operative complications originate: wound infection, incisional hernia, increased pain, delayed mobility, and extended opioid use.
The NICE procedure eliminates it entirely. The specimen is extracted transrectally — using the rectum as a natural pathway — and the patient leaves the OR with four small port sites, each roughly the size of a dime, and no abdominal extraction wound.
The published clinical impact of eliminating that incision includes:
Shorter hospital stay. Faster recovery.
The absence of an abdominal incision directly shortens every phase of recovery — from time spent in hospital to time before returning to work and normal activity.
Houston Colon’s published NICE procedure cohort shows a median hospital stay of 2.4 days, compared to a national average of 5–8 days for conventional colorectal surgery.
Bowel function returns at a median of 20 hours post-operatively, compared with several days following conventional approaches, and most patients return to normal activity within 2–3 weeks, compared with 6–12 weeks following open surgery.
The structured enhanced recovery protocol used at Houston Colon compounds these results, combining the inherent benefits of the NICE approach with a multimodal opioid-sparing post-operative plan that further accelerates recovery.
Reduced pain. Lower opioid requirements.
Eliminating the abdominal incision removes the primary source of somatic pain following colorectal surgery.
With less pain comes a reduced need for opioids, and that reduction has significant downstream consequences for recovery.
Opioid use after colorectal surgery is the leading cause of post-operative ileus — the delay in bowel function that prolongs hospital stay, increases patient discomfort, and adds clinical risk.
Houston Colon’s published data shows that only 2.6% of patients undergoing the NICE procedure experienced post-operative ileus. This result reflects both the reduced pain burden of the procedure and the practice’s opioid-sparing enhanced recovery protocol.
Consistent outcomes — even in high-BMI patients
Minimally invasive colorectal surgery traditionally becomes more technically challenging and carries a greater complication risk in patients with higher BMI.
Abdominal extraction incisions are harder to close, more prone to infection, and more likely to result in hernia formation in this population.
The NICE procedure performs consistently across BMI ranges.
In Houston Colon’s published research, 34.3% of patients had a BMI of 30 or higher — consistent with the broader Texas patient population, per CDC data.
BMI was not associated with failure to achieve transrectal extraction or complete an intracorporeal anastomosis.
For patients evaluating candidacy, body weight is not a disqualifying factor for the NICE procedure at Houston Colon.
Validated for diverticulitis and colon cancer
The NICE procedure has been clinically validated for both left-sided diverticulitis and colon cancer surgery. It is now Houston Colon’s primary surgical approach for left-sided colorectal resection in both indications.
In the published 306-patient cohort, diverticulitis represented 64% of cases, including complicated presentations involving fistula, abscess, and stricture, and colorectal neoplasm accounted for 27%. Outcomes were consistent across both groups.
Notably, outcomes in complicated diverticulitis cases matched those of uncomplicated cases, with identical anastomosis success rates, a median hospital stay of 2 days, and nearly identical opioid consumption, demonstrating that the NICE procedure’s benefits do not depend on case simplicity.
Testimonials
Frequently asked questions
The NICE procedure extracts the specimen through the rectum, leaving only four small port sites.
Combined with Houston Colon’s structured recovery protocol, most patients are discharged within 2–3 days and return to normal activity within 2–3 weeks.
Candidacy depends on specific diagnosis, anatomy, and clinical history. Houston Colon’s fellowship-trained surgeons evaluate each patient individually before recommending an approach.